期刊
DIGESTIVE DISEASES AND SCIENCES
卷 58, 期 6, 页码 1790-1796出版社
SPRINGER
DOI: 10.1007/s10620-012-2527-3
关键词
HCC; Size; Thrombocytosis; Portal vein thrombosis
资金
- NCI NIH HHS [R01 CA082723] Funding Source: Medline
Background Thrombocytopenia has been reported to be both a risk factor for hepatocellular carcinoma (HCC) development as well as a prognostic factor. Many HCCs also occur in presence of normal platelets. Aim To examine a cohort of HCC patients with associated thrombocytosis. Methods Records were examined of a cohort of 634 biopsy-proven and randomly presenting HCC patients without thrombocytopenia. Results In the total cohort, 52 patients were identified with thrombocytosis (platelet levels >400 x10(9)/L) and compared with 582 patients with normal platelet values. The average tumor sizes were 13.1 versus 8.8 cm (p < 0.0001), and their total average bilirubin levels were 0.9 versus 1.5 (p = 0.02), comparing thrombocytosis patients versus normal platelet count HCC patients. These differences were even more pronounced in patients with HCC sizes >5 cm. Thrombocytosis patients were younger and had less cirrhosis, but similar percent with hepatitis B or C or alcohol consumption. Conclusion Thrombocytosis in association with HCC occurs in patients with larger tumor sizes and better liver function.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据